Wakeling A E, Bowler J
Imperial Chemical Industries plc, Pharmaceuticals Division, Cheshire, England.
J Steroid Biochem. 1988 Oct;31(4B):645-53. doi: 10.1016/0022-4731(88)90014-3.
The oestrogenic and antioestrogenic properties of some novel 7 alpha-alkyl amide derivatives of 17 beta-oestradiol have been measured in rats and mice. The compound ICI 164384 was devoid of oestrogenic activity in the uterus and vagina of both species and on the hypothalamic-pituitary axis of the rat. ICI 164384 blocked completely the uterotrophic action of exogenous and endogenous oestradiol and of the partial agonist antioestrogens typified by tamoxifen. Unlike tamoxifen ICI 164384 did not promote premature vaginal opening in neonatal rats. The affinity of ICI 164384 for the rat uterus oestrogen receptor was substantially greater than that of tamoxifen. In MCF-7 and ZR-75-1 breast cancer cells in tissue culture ICI 164384 was a more potent inhibitor of cell growth than tamoxifen and growth inhibition was reversed by oestradiol. The properties of ICI 164384 satisfy many of the criteria which define pure antioestrogens.
已在大鼠和小鼠中测定了一些新型17β-雌二醇7α-烷基酰胺衍生物的雌激素和抗雌激素特性。化合物ICI 164384在这两种物种的子宫和阴道以及大鼠的下丘脑-垂体轴上均无雌激素活性。ICI 164384完全阻断了外源性和内源性雌二醇以及以他莫昔芬为代表的部分激动剂抗雌激素的子宫营养作用。与他莫昔芬不同,ICI 164384不会促进新生大鼠的阴道过早开放。ICI 164384对大鼠子宫雌激素受体的亲和力明显大于他莫昔芬。在组织培养的MCF-7和ZR-75-1乳腺癌细胞中,ICI 164384比他莫昔芬更有效地抑制细胞生长,并且雌二醇可逆转生长抑制。ICI 164384的特性满足了定义纯抗雌激素的许多标准。